Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children
Introduction. Levosimendan is a novel positive inotropic agent which, improves myocardial contractility through its calcium-sensitizing action, without causing an increase in myocardial oxygen demand. Also, by opening ATP-sensitive potassium channels, it causes vasodilatation with the reduction...
Main Authors: | Prijić Sergej, Rakić Sanja, Nikolić Ljubica, Jovičić Bosiljka, Stajević Mila, Vukomanović Vladislav, Košutić Jovan |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2011-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501111979P.pdf |
Similar Items
-
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
by: Mads D. Lyhne, et al.
Published: (2021-06-01) -
The analysis of the risk factors in the arterial switch operation for treatment of D-transposition of the great arteries in one Pediatric Cardiac Center in Serbia
by: Stajević-Popović Mila, et al.
Published: (2015-01-01) -
Comparison of Levosimendan, Milrinone and Dobutamine in treating Low Cardiac Output Syndrome Following Valve Replacement Surgeries with Cardiopulmonary Bypass
by: Sunny, et al.
Published: (2016-12-01) -
Stenting aortic coarctation in children: Immediate and midterm results
by: Kuburović Vladimir, et al.
Published: (2011-01-01) -
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
by: William Juguet, et al.
Published: (2020-11-01)